These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
447 related items for PubMed ID: 18289144
1. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. Kim SW, Shin IS, Kim JM, Kim YC, Kim KS, Kim KM, Yang SJ, Yoon JS. Psychiatry Clin Neurosci; 2008 Feb; 62(1):75-83. PubMed ID: 18289144 [Abstract] [Full Text] [Related]
2. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study. Varia I, Venkataraman S, Hellegers C, Gersing K, Doraiswamy PM. Psychopharmacol Bull; 2007 Feb; 40(1):47-56. PubMed ID: 17285095 [Abstract] [Full Text] [Related]
3. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study. Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED. J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411 [Abstract] [Full Text] [Related]
4. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home. Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H, Mirtazapine in the Nursing Home Study Group. Curr Med Res Opin; 2003 Aug; 19(8):737-46. PubMed ID: 14687445 [Abstract] [Full Text] [Related]
5. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial. Kim JE, Yoon SJ, Kim J, Jung JY, Jeong HS, Cho HB, Shin E, Lyoo IK, Kim TS. Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870 [Abstract] [Full Text] [Related]
6. The effect of mirtazapine in patients with chronic pain and concomitant depression. Freynhagen R, Muth-Selbach U, Lipfert P, Stevens MF, Zacharowski K, Tölle TR, von Giesen HJ. Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597 [Abstract] [Full Text] [Related]
7. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression. Malhi GS, Ng F, Berk M. Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778 [Abstract] [Full Text] [Related]
9. Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study. Yoon SJ, Pae CU, Kim DJ, Namkoong K, Lee E, Oh DY, Lee YS, Shin DH, Jeong YC, Kim JH, Choi SB, Hwang IB, Shin YC, Cho SN, Lee HK, Lee CT. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1196-201. PubMed ID: 16624467 [Abstract] [Full Text] [Related]
10. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group. Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT. Int Clin Psychopharmacol; 1999 Nov 30; 14(6):329-37. PubMed ID: 10565799 [Abstract] [Full Text] [Related]
11. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation. Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G. Eur Neuropsychopharmacol; 2009 Jul 30; 19(7):457-65. PubMed ID: 19345072 [Abstract] [Full Text] [Related]
12. Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology. Thompson DS. Psychosomatics; 2000 Jul 30; 41(4):356-9. PubMed ID: 10906359 [No Abstract] [Full Text] [Related]
13. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. Wade A, Crawford GM, Angus M, Wilson R, Hamilton L. Int Clin Psychopharmacol; 2003 May 30; 18(3):133-41. PubMed ID: 12702891 [Abstract] [Full Text] [Related]
14. Anxiety and depression after lung transplantation: Mirtazapine as a first-choice agent? Fusar-Poli P, Matteo L, Luca de M, Politi P, Cortesi M, Carboni V. J Psychosom Res; 2007 Jan 30; 62(1):101. PubMed ID: 17188127 [No Abstract] [Full Text] [Related]
15. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety. Wålinder J, Prochazka J, Odén A, Sjödin I, Dahl ML, Ahlner J, Bengtsson F. Hum Psychopharmacol; 2006 Apr 30; 21(3):151-8. PubMed ID: 16444795 [Abstract] [Full Text] [Related]
16. Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine. Cankurtaran ES, Ozalp E, Soygur H, Akbiyik DI, Turhan L, Alkis N. Support Care Cancer; 2008 Nov 30; 16(11):1291-8. PubMed ID: 18299900 [Abstract] [Full Text] [Related]
17. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study. Saiz-Ruiz J, Montes JM, Ibáñez A, Díaz M, Vicente F, Pelegrín C, Viñas R, Arias F, Carrasco JL, Ferrando L. Hum Psychopharmacol; 2005 Aug 30; 20(6):435-40. PubMed ID: 16106478 [Abstract] [Full Text] [Related]
18. Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older. Nelson JC, Hollander SB, Betzel J, Smolen P, Mirtazapine Nursing Home Study Group. Int J Geriatr Psychiatry; 2006 Sep 30; 21(9):898-901. PubMed ID: 16955423 [Abstract] [Full Text] [Related]
19. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division. Pasquini M, Biondi M, Costantini A, Cairoli F, Ferrarese G, Picardi A, Sternberg C. Depress Anxiety; 2006 Sep 30; 23(7):441-8. PubMed ID: 16841345 [Abstract] [Full Text] [Related]
20. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression. van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J. Int Clin Psychopharmacol; 1995 Mar 30; 10(1):3-9. PubMed ID: 7622801 [Abstract] [Full Text] [Related] Page: [Next] [New Search]